Skip to Main Content

Seres Therapeutics, Inc.

MCRB Real Time Price USD
N/A
N/A
N/A
...
Overview
Financials
Insiders
Institutions
Government
Ownership
Income
Balance Sheet
Cash Flow
MCRB Income Statement
MCRB Balance Sheet
MCRB Cash Flow

Recent trades of MCRB by members of U.S. Congress

Quiver Logo

No Congress Trading data for this ticker

Congress Trading Dashboard
MCRB Stock Insider Trading Activity
Name
Type
Shares
Price
Shares Held
Date
Reported
MCRB Stock Institutional Owners
Investor
Shares
Change in Shares
Market Value
Date
Reported
MCRB Derivatives Institutional Owners
Investor
Type
Shares
Change in Shares
Market Value
Date
Reported

Recently reported changes by institutional investors

Quarterly net insider trading by MCRB's directors and management

Government lobbying spending instances

Quiver Logo

No Corporate Lobbying instances for this ticker

Corporate Lobbying Dashboard

Estimated quarterly lobbying spending

Quiver Logo

No Corporate Lobbying data for this ticker

Corporate Lobbying Dashboard
U.S. Patents

New patents grants

  • Patent Title: Synergistic bacterial compositions and methods of production and use thereof Sep. 10, 2024
  • Patent Title: Synergistic bacterial compositions and methods of production and use thereof Mar. 05, 2024
  • Patent Title: Methods for treatment of clostridium difficile infection or recurrence or symptoms thereof Aug. 22, 2023
  • Patent Title: Compositions and methods for treating cholestatic disease Jul. 18, 2023
  • Patent Title: Network-based microbial compositions and methods Jun. 06, 2023
  • Patent Title: Synergistic bacterial compositions and methods of production and use thereof Oct. 11, 2022
  • Patent Title: Synergistic bacterial compositions and methods of production and use thereof Oct. 04, 2022
  • Patent Title: Synergistic bacterial compositions and methods of production and use thereof Oct. 04, 2022
  • Patent Title: Synergistic bacterial compositions and methods of production and use thereof Jul. 19, 2022
  • Patent Title: Synergistic bacterial compositions and methods of production and use thereof Mar. 08, 2022
  • Patent Title: Compositions and methods for inhibition of pathogenic bacterial growth Nov. 30, 2021
  • Patent Title: Compositions and methods Apr. 13, 2021
  • Patent Title: Compositions and methods Apr. 06, 2021
  • Patent Title: Network-based microbial compositions and methods Jan. 05, 2021
  • Patent Title: Synergistic bacterial compositions and methods of production and use thereof Dec. 15, 2020
  • Patent Title: Synergistic bacterial compositions and methods of production and use thereof Apr. 16, 2019
  • Patent Title: Network-based microbial compositions and methods Sep. 18, 2018
  • Patent Title: Compositions and methods Sep. 04, 2018
  • Patent Title: Methods of populating a gastrointestinal tract Sep. 04, 2018
  • Patent Title: Bacterial compositions and methods of use thereof for treatment of immune system disorders May. 01, 2018
  • Patent Title: Compositions and methods Jan. 02, 2018
  • Patent Title: Compositions and methods Mar. 07, 2017
  • Patent Title: Synergistic bacterial compositions and methods of production and use thereof Jan. 03, 2017
  • Patent Title: Compositions and methods Sep. 20, 2016
  • Patent Title: Compositions and methods Nov. 10, 2015
Government Contracts

Federal grants, loans, and purchases

Quiver Logo

No Government Contracts for this ticker

Government Contracts Dashboard
Government Contracts

Estimated quarterly amount awarded from public contracts

Quiver Logo

No recent Government Contracts for this ticker

Government Contracts Dashboard
WallStreetBets

Number of mentions of MCRB in WallStreetBets Daily Discussion

MCRB News

Recent insights relating to MCRB

CNBC Recommendations

Recent picks made for MCRB stock on CNBC

Top ETF Holders

ETFs with the largest estimated holdings in MCRB

MCRB Top Shareholders
Shareholder
Shares Held
MCRB Options Owners
Shareholder
Security
Underlying Shares

* These are estimates based on data taken from SEC filings. There may be inaccuracies due to parsing errors, accidental double-counting, incorrect classification of indirectly owned shares, or any other number of issues.

MCRB Stock Smart Score

The Quiver Smart Score combines our data on Congress Trading, Lobbying, Insider Trading, CNBC Mentions and more to provide a comprehensive view of the strength of a stock's underlying data.

The Smart Score grades stocks on a scale of 1 (weakest) to 10 (strongest) based on the strength of the underlying data.
?

Sign Up to view MCRB Smart Score

Score Breakdown
Bull Case vs Bear Case

See concise summaries of analyst reports, presenting both bullish and bearish arguments for a stock.

Example:

Bulls Say:

The Bulls Say summary highlights positive aspects of the stock.

Bears Say:

The Bears Say summary points out potential risks and negative aspects of the stock.

Show More
Back To Top